Peter Doshi, PhD told the FDA the Risks Outweigh Benefits of C-19 Shots for Children

On June 10, 2021, the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) met to discuss the current science and data on COVID-19 and the COVID-19 vaccines in pediatric populations, whether giving the shots Emergency Use Authorization (EUA) status for younger kids was justified, or licensing, and if so, when and based on what.

Peter Doshi, PhD told the FDA the clinical trial data showed the risks of the shots are greater than the benefit.